CI Stock Recent News
CI LATEST HEADLINES
CVS Health, UnitedHealth Group and Cigna sued the Federal Trade Commission, claiming the agency's case against drug middlemen over high insulin prices in the U.S. is unconstitutional. The complaint is the latest move in a bitter legal fight between the three largest pharmacy benefit managers, or PBMs, in the U.S. and the FTC.
CI reaffirms its 2024 outlook, projecting full-year adjusted EPS to be a minimum of $28.40.
Victoria Greene, G Squared Private Wealth CIO, joins CNBC's 'Power Lunch' to discuss three stocks: Cigna, Coinbase, and Draft Kings.
The Cigna Group confirmed “it is not pursuing a combination with Humana.”
Shares of Humana Inc (NYSE:HUM) are down 3.7% at $277.38 at last glance, after Cigna Group (NYSE:CI) said it was not pursuing a merger with the smaller health insurance name, and will instead prioritize share buybacks.
US health insurer Cigna has made the appropriate decision to ditch plans to merge with rival Humana (NYSE:HUM), if today's market reaction is anything to go by. Rumours of the merger, which would have created a $140 billion insurance behemoth, began circulating last December, but doubts over the deal quickly followed.
Investors have long appeared skeptical about a potential merger between the two health insurers.
Health insurer Cigna Group said on Monday it is not pursuing a combination with peer Humana.
Reaffirming Previously Provided Outlook for Full-Year 2024, and adjusted EPS growth of at least 10% in 2025 Confirming it is not Pursuing a Combination with Humana Inc. Confirming Continuing to Use Capital to Drive Shareholder Value, including Share Repurchase and Dividends BLOOMFIELD, Conn. , Nov. 11, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) officials expect to participate in meetings with investors and analysts over the next several weeks.